09 Jan Phase 3 of Zorevunersen Study
Stoke Therapeutics, a biotechnology company that works on a proposed...
Author: DSEF
25 Sep SCN1A-UP! at the end – Gene therapy approaches
In this video, Dr Gaia Colasante summarizes the strategies and...
24 Sep SCN1A-UP! at the end – project outcomes
In the video above, Dr Massimo Mantegazza, the coordinator of...
23 Sep The European Epilepsy Congress Rome 2024
The European Epilepsy Congress has shown significant growth in recent...
30 Jul Research: Project SCN1A-UP! Therapeutic strategies for Dravet syndrome
The project SCN1A-UP!, coordinated by Dr Massimo Mantegazza and funded...
18 Jul New tool to improve quality of life of Dravet patients and their families
The development of more effective support systems and an enhanced...
19 Oct SUDEP – An uncomfortable but necessary discussion
SUDEP is that kind of word you don't want to...
23 Jun Dravet Awareness Day 2022
We are smiling, we are kind, we are fearless, we...
22 Jun SUDEP forum at EEC2022 Geneva
Almost all discussions around Dravet Syndrome are uncomfortable but necessary....
29 Dec New Chief Scientific Officer for DSEF
The Dravet Syndrome European Federation is happy to announce the...